Influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma: a meta-analysis of observational studies

World Journal of Surgical Oncology

Zhiming Zhang³  Bin Li¹  Xu Su¹  Lupeng Wu¹  Xiaoying Si²  Yanming Zhou¹ 

[1] Department of Hepato-Biliary-Pancreato-Vascular Surgery, the First affiliated Hospital of Xiamen University, Xiamen, China;Department of Blood Transfution, the First affiliated Hospital of Xiamen University, Xiamen, China;Cancer Center, the First affiliated Hospital of Xiamen University, Xiamen, China

关键词: Prognosis;    Hepatitis C;    Hepatitis B;    Viral infection;    Hepatocellular carcinoma;   

Others  :  1206656
DOI  :  10.1186/1477-7819-9-108

 received in 2011-07-09, accepted in 2011-09-21,  发布年份 2011

【 摘 要 】

Background

The influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma (HCC) remains a matter of debate. This study is a meta-analysis of the available evidence.

Methods

A literature search was performed to identify comparative studies reporting postoperative survival of HCC in different types of viral hepatitis. Pooled odds ratios (OR) and weighted mean differences (WMD with 95% confidence intervals (95% CI) were calculated using either the fixed effects model or random effects model.

Results

Twenty studies matched the selection criteria and reported on 4744 subjects, of whom 2008 in the HBV-positive (B-HCC) group, 2222 in the HCV-positive (C-HCC) group, and 514 in the hepatitis B- and C-negative (NBNC-HCC). Meta-analysis showed that patients with HBV or HCV infection had a worse 5-year disease-free survival when compared to patients with NBNC-HCC (respectively: OR: 0.39, 95% CI: 0.28 to 0.53, P < 0.001; WMD: 0.37, 95% CI: 0.22 to 0.64, P < 0.001). There was a tendency toward higher 5-year overall survival rates in the NBNC-HCC group compared to those in the other two groups, although these differences were not statistically significant. Both the 5-year overall survival and disease-free survival were not different among the B-HCC and C-HCC groups.

Conclusions

Patients with positive serology for hepatitis B or C undergoing resection for HCC had a poor prognosis compared to patients with negative serology.

【 授权许可】

   
2011 Zhou et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Llovet JM, Burroughs A, Bruix J: Hepatocellular carcinoma. Lancet 2003, 362:1907-17.
• [2]Bosch FX, Ribes J, Díaz M, Cléries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004, 127:S5-S16.
• [3]Yamanaka N, Tanaka T, Tanaka W, Yamanaka J, Yasui C, Kuroda N, Takada M, Okamoto E: Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma. Cancer 1997, 79:1509-15.
• [4]Lee WC, Jeng LB, Chen MF: Hepatectomy for hepatitis B-, hepatitis C-, and dual hepatitis B- and C-related hepatocellular carcinoma in Taiwan. J Hepatobiliary Pancreat Surg 2000, 73:265-9.
• [5]Pawlik TM, Poon RT, Abdalla EK, Sarmiento JM, Ikai I, Curley SA, Nagorney DM, Belghiti J, Ng IO, Yamaoka Y, Lauwers GY, Vauthey JN: Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma. J Gastrointest Surg 2004, 8:794-804.
• [6]Huo TI, Huang YH, Hsia CY, Su CW, Lin HC, Hsu CY, Lee PC, Lui WY, Loong CC, Chiang JH, Chiou YY, Lee SD: Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection? Liver Int 2009, 29:767-73.
• [7]Akahoshi H, Taura N, Ichikawa T, Miyaaki H, Akiyama M, Miuma S, Ozawa E, Takeshita S, Muraoka T, Matsuzaki T, Ohtani M, Isomoto H, Matsumoto T, Takeshima F, Nakao K: Differences in prognostic factors according to viral status in patients with hepatocellular carcinoma. Oncol Rep 2010, 23:1317-23.
• [8]Aziz O, Constantinides V, Tekkis PP, Athanasiou T, Purkayastha S, Paraskeva P, Darzi AW, Heriot AG: Laparoscopic versus open surgery for rectal cancer: a meta-analysis. Ann Surg Oncol 2006, 13:413-24.
• [9]Rao B, Han M, Wang L, Gao X, Huang J, Huang M, Liu H, Wang J: Clinical outcomes of active specific immunotherapy in advanced colorectal cancer and suspected minimal residual colorectal cancer: a meta-analysis and system review. J Transl Med 2011, 9:17. BioMed Central Full Text
• [10]Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, Teratani T, Tohgo G, Toda N, Ohashi M, et al.: Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology 1995, 22:1027-33.
• [11]Tanizaki H, Ryu M, Kinoshita T, Kawano N, Konishi M, Cho A, Nakatsura T, Natsume T, Takahashi S, Sugita M, Izuishi K, Yoshino M, Furuse J, Iwasaki M, Tsubono Y: Comparison of clinical features and survival in patients with hepatitis B and C virus-related hepatocellular carcinoma. Jpn J Clin Oncol 1997, 27:67-70.
• [12]Tanabe G, Nuruki K, Baba Y, Imamura Y, Miyazono N, Ueno K, Arima T, Nakajyou M, Aikou T: A comparison of hepatocellular carcinoma associated with HBV or HCV infection. Hepatogastroenterology 1999, 46:2442-6.
• [13]Watabe H, Shiratori Y, Tateishi R, Fujishima T, Akamatsu M, Koike Y, Obi S, Hamamura K, Sato S, Teratani T, Shiina S, Omata M: Clinical features of patients with HCC who are negative for both HBV and HCV markers. Hepatogastroenterology 2003, 50:2157-60.
• [14]Dohmen K, Shigematsu H, Irie K, Ishibashi H: Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients. Hepatogastroenterology 2003, 50:2022-7.
• [15]Tangkijvanich P, Suwangool P, Mahachai V: Comparison of clinical features and survival of patients with hepatitis B- and hepatitis C-associated hepatocellular carcinoma in Thailand. J Med Assoc Thai 2003, 86(Suppl 2):S250-6.
• [16]Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, Hamamura K, Imai Y, Yoshida H, Shiina S, Omata M: Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion. Hepatology 2000, 32:1216-23.
• [17]Chen CH, Huang GT, Yang PM, Chen PJ, Lai MY, Chen DS, Wang JD, Sheu JC: Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis. Eur J Cancer 2006, 42:2524-9.
• [18]Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J: Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma. J Gastroenterol Hepatol 2008, 23:459-66.
• [19]Higashi H, Matsumata T, Adachi E, Taketomi A, Kashiwagi S, Sugimachi K: Influence of viral hepatitis status on operative morbidity and mortality in patients with primary hepatocellular carcinoma. Br J Surg 1994, 81:1342-5.
• [20]Higashi Y, Tada S, Miyase S, Hirota K, Imamura H, Kamio T, Suko H: Correlation of clinical characteristics with detection of hepatitis B virus × gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients. Liver 2002, 22:374-9.
• [21]Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, Lui WY, Chang FY, Lee SD: Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area. Liver Int 2005, 25:236-41.
• [22]Huo TI, Wu JC, Hsia CY, Chau GY, Lui WY, Huang YH, Lee PC, Chang FY, Lee SD: Hepatitis C virus infection is a risk factor for tumor recurrence after resection of small hepatocellular carcinomas. World J Surg 2004, 28:787-91.
• [23]Yamanaka N, Takada M, Tanaka T, Yamanaka J, Yasui C, Ando T, Maeda S, Matsushita K, Okamoto E: Viral serostatus and coexisting inflammatory activity affect metachronous carcinogenesis after hepatectomy for hepatocellular carcinoma. A further report. J Gastroenterol 2000, 35:206-13.
• [24]Chen MF, Jeng LB, Lee WC, Chen TC: Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma. Surgery 1998, 123:554-9.
• [25]Chen MF, Jeng LB, Lee WC: Surgical results in patients with hepatitis virus-related hepatocellular carcinoma in Taiwan. World J Surg 2002, 26:742-7.
• [26]Wu CC, Ho WL, Chen JT, Tang JS, Yeh DC, P'eng FK: Hepatitis viral status in patients undergoing liver resection for hepatocellular carcinoma. Br J Surg 1999, 86:1391-6.
• [27]Li Q, Li H, Qin Y, Wang PP, Hao X: Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience. J Gastroenterol Hepatol 2007, 22:1936-41.
• [28]Nanashima A, Abo T, Sumida Y, Takeshita H, Hidaka S, Furukawa K, Sawai T, Yasutake T, Masuda J, Morisaki T, Nagayasu T: Clinicopathological characteristics of patients with hepatocellular carcinoma after hepatectomy: relationship with status of viral hepatitis. J Surg Oncol 2007, 96:487-92.
• [29]Cescon M, Cucchetti A, Grazi GL, Ferrero A, Viganò L, Ercolani G, Ravaioli M, Zanello M, Andreone P, Capussotti L, Pinna AD: Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience. Arch Surg 2009, 144:906-13.
• [30]Takenaka K, Yamamoto K, Taketomi A, Itasaka H, Adachi E, Shirabe K, Nishizaki T, Yanaga K, Sugimachi K: A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma. Hepatology 1995, 22:20-4.
• [31]Miyagawa S, Kawasaki S, Makuuchi M: Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C. Hepatology 1996, 24:307-10.
• [32]Shiraishi M, Hiroyasu S, Nagahama M, Tomita S, Miyahira T, Kusano T, Furukawa M, Muto Y: Characteristics of hepatocellular carcinoma in patients with negative virus markers: clinicopathologic study of resected tumors. World J Surg 1999, 23:301-5.
• [33]Noguchi K, Nakashima O, Nakashima Y, Shiota K, Nawata H, Kojiro M: Clinicopathologic study on hepatocellular carcinoma negative for hepatitis B surface antigen and antibody to hepatitis C virus. Int J Mol Med 2000, 6:661-5.
• [34]Roayaie S, Haim MB, Emre S, Fishbein TM, Sheiner PA, Miller CM, Schwartz ME: Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience. Ann Surg Oncol 2000, 7:764-70.
• [35]Ahmad SA, Bilimoria MM, Wang X, Izzo F, Delrio P, Marra P, Baker TP, Porter GA, Ellis LM, Vauthey JN, Dhamotharan S, Curley SA: Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma. J Gastrointest Surg 2001, 5:468-76.
• [36]Chen TH, Tseng LM, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hsia CY, Wu CW: Clinicopathologic and prognostic differences between patients with hepatitis B- and C-related resectable hepatocellular carcinoma. J Formos Med Assoc 2001, 100:443-8.
• [37]Wakai T, Shirai Y, Yokoyama N, Nagakura S, Hatakeyama K: Hepatitis viral status affects the pattern of intrahepatic recurrence after resection for hepatocellular carcinoma. Eur J Surg Oncol 2003, 29:266-71.
• [38]Yokoi Y, Suzuki S, Baba S, Inaba K, Konno H, Nakamura S: Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection. J Gastroenterol 2005, 40:274-82.
• [39]Uchiyama K, Ueno M, Hama T, Kawai M, Tani M, Terasawa H, Ozawa S, Uemura R, Nakase T, Yamaue H: Recurrence of primary hepatocellular carcinoma after hepatectomy--differences related to underlying hepatitis virus species. Hepatogastroenterology 2005, 52:591-5.
• [40]Sasaki Y, Yamada T, Tanaka H, Ohigashi H, Eguchi H, Yano M, Ishikawa O, Imaoka S: Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma. Ann Surg 2006, 244:771-80.
• [41]Kondo K, Chijiiwa K, Funagayama M, Kai M, Otani K, Ohuchida J: Differences in long-term outcome and prognostic factors according to viral status in patients with hepatocellular carcinoma treated by surgery. J Gastrointest Surg 2008, 12:468-76.
• [42]Kao WY, Su CW, Chau GY, Lui WY, Wu CW, Wu JC: A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery. World J Surg 2011, 35:858-67.
• [43]Chan HL, Sung JJ: Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis 2006, 26:153-61.
• [44]Castello G, Costantini S, Scala S: Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment. J Transl Med 2010, 8:109. BioMed Central Full Text
• [45]De Maria N, Manno M, Villa E: Sex hormones and liver cancer. Mol Cell Endocrinol 2002, 193:59-63.
• [46]Wang AG, Lee KY, Kim SY, Choi JY, Lee KH, Kim WH, Wang HJ, Kim JM, Park MG, Yeom YI, Kim NS, Yu DY, Lee DS: The expression of estrogen receptors in hepatocellular carcinoma in Korean patients. Yonsei Med J 2006, 47:811-6.
• [47]Chiu CM, Yeh SH, Chen PJ, Kuo TJ, Chang CJ, Chen PJ, Yang WJ, Chen DS: Hepatitis B virus × protein enhances androgen receptor-responsive gene expression depending on androgen level. Proc Natl Acad Sci USA 2007, 104:2571-8. 20
• [48]Zhou Y, Sui C, Li B, Yin Z, Tan Y, Yang J, Liu Z: Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review. World J Surg Oncol 2010, 8:55. BioMed Central Full Text
• [49]Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T, Kawasaki S, Makuuchi M: Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003, 38:200-7.
• [50]Squadrito G, Pollicino T, Cacciola I, Caccamo G, Villari D, La Masa T, Restuccia T, Cucinotta E, Scisca C, Magazzu D, Raimondo G: Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. Cancer 2006, 106:1326-30.
• [51]McKay A, Mackenzie S, Sutherland FR, Bathe OF, Doig C, Dort J, Vollmer CM Jr, Dixon E: Meta-analysis of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy. Br J Surg 2006, 93:929-36.
• [52]Miao RY, Zhao HT, Yang HY, Mao YL, Lu X, Zhao Y, Liu CN, Zhong SX, Sang XT, Huang JF: Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma: a meta-analysis. World J Gastroenterol 2010, 16:2931-42.